Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

AIM: Biological disease-modifying antirheumatic drugs (bDMARDs) are used to treat rheumatoid arthritis (RA) with adalimumab and etanercept the most used bDMARDs in Brazil. This open prospective cohort study evaluated their effectiveness and safety among RA patients in the Brazilian Public Health Sys...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Comp Eff Res
Päätekijät: dos Santos, Jéssica Barreto Ribeiro, Almeida, Alessandra Maciel, Acurcio, Francisco de Assis, de Oliveira Junior, Haliton Alves, Kakehasi, Adriana Maria, Guerra Junior, Augusto Afonso, Bennie, Marion, Godman, Brian, Alvares, Juliana
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5097454/
https://ncbi.nlm.nih.gov/pubmed/27641309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer-2016-0027
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia